LEONARD FRANK X (Chief Development Officer) sold 4.6% of their position (16.97K shares) of NOVOCURE LTD on the open market
Open‑market sale worth $230.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/3/2026ACC: 0001822879-26-000002
Officer· Chief Development Officer
Since Sep 2020
+1.66K
Net shares
Net buyer
$230.6K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
18.62K acquired · 16.97K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−9.73K
Price / share
$13.66
Trade value
$133K
% of position
2.8%
2/27/2026
347.75K→338.01K
Ordinary Shares
Direct
Shares
+18.62K
Price / share
—
Trade value
—
% of position
5.5%
2/28/2026
338.01K→356.63K
Ordinary Shares
Direct
Shares
−7.23K
Price / share
$13.49
Trade value
$97.58K
% of position
2.0%
3/2/2026
356.63K→349.40K
Total
Net shares
+1.66K
Net value
-$230.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/27/2026 | S · Sale | −9.73K | $13.66 | $133K | 2.8% | 347.75K | 338.01K |
| Ordinary Shares Direct | 2/28/2026 | A · Award | +18.62K | — | — | 5.5% | 338.01K | 356.63K |
| Ordinary Shares Direct | 3/2/2026 | S · Sale | −7.23K | $13.49 | $97.58K | 2.0% | 356.63K | 349.40K |
| Total | +1.66K | -$230.58K | ||||||
Derivative Transactions0
No derivative transactions reported